Controlled Substances - As enacted, authorizes additional healthcare providers to directly administer buprenorphine mono or buprenorphine without the use of naloxone; adds that prescribing a buprenorphine product to nursing mother or prescribing an injectable mono product does not restrict certain healthcare providers from prescribing a buprenorphine product for the treatment of opioid use disorder without naloxone. - Amends TCA Title 53, Chapter 11.

SB 1848 amends Tennessee law to expand access to buprenorphine treatment for opioid use disorder by allowing more healthcare providers (beyond physicians) to directly administer buprenorphine without naloxone, acting within their scope of practice. The bill specifically permits prescribing to nursing mothers and patients with documented adverse reactions to naloxone, and clarifies that prescribing injectable forms doesn't restrict providers from prescribing buprenorphine without naloxone. These changes aim to streamline treatment options while maintaining safety protocols for specific patient groups. The bill modifies Tennessee Code Annotated Sections 53-11-311(b)(1) and (c)(2).